- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Integrated Pulmonary Index in South Africa
Total 805 results
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease COPDUnited States, Netherlands, Argentina, South Africa, Chile, Peru
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease, COPD | Low Peak Inspiratory Flow Rate (PIFR)United States
-
Sheffield Teaching Hospitals NHS Foundation TrustNovartisCompleted
-
DeyCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Chiesi Farmaceutici S.p.A.Chiesi USA, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States, Czech Republic, Germany, Poland, Romania, South Africa
-
Macquarie University, AustraliaCompletedChronic Obstructive Pulmonary Disease (COPD)Australia
-
University of AthensCompletedAcute Respiratory Distress Syndrome | Acute Cor PulmonaleGreece
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPDUnited States, France, Poland, South Africa, Canada, Germany
-
RMT Medical Technologies, Ltd.CompletedPulmonary EmbolismUnited States, Austria, Greece, Israel, South Africa, United Kingdom
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseUnited States, Germany
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseAustralia, United States, New Zealand
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
SunovionCompletedChronic Obstructive Pulmonary DiseaseUnited States
-
University of SheffieldUnknownAnxiety Disorders | Anxiety | Pulmonary Arterial Hypertension | Pulmonary HypertensionUnited Kingdom
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Chiesi Farmaceutici S.p.A.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
Pharmosa Biopharm Inc.Novotech (Australia) Pty LimitedRecruitingPulmonary Arterial HypertensionAustralia
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveAustralia, New Zealand, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Russian Federation, Estonia, Netherlands, South Africa, Korea, Republic of, Slovenia, New Zealand, Finland, Latvia, Lithuania, United Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveGermany, Romania, Ukraine, Estonia, Russian Federation, South Africa, Sweden, Netherlands, Slovakia
-
Sheffield Teaching Hospitals NHS Foundation TrustRecruiting
-
Medical University of South CarolinaOchsner Health SystemTerminatedPulmonary Arterial HypertensionUnited States
-
siRNAgen Therapeutics Inc.Active, not recruiting
-
Endeavor Biomedicines, Inc.CompletedIdiopathic Pulmonary FibrosisAustralia
-
Respira Therapeutics, Inc.CompletedPulmonary Arterial HypertensionAustralia
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUnited Kingdom
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedPulmonary HypertensionUnited Kingdom
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveSouth Africa, United States, Canada, Ukraine, United Kingdom, Denmark, Czechia
-
VA Office of Research and DevelopmentMinneapolis Veterans Affairs Medical Center; Ralph H. Johnson VA Medical CenterEnrolling by invitationTobacco Use | Multiple Pulmonary Nodules | Solitary Pulmonary NoduleUnited States
-
Gmax Biopharm Australia Pty Ltd.Metaclinical; Syneos HeathCompletedPulmonary Arterial HypertensionAustralia
-
University of California, San FranciscoJohns Hopkins UniversityNot yet recruitingTuberculosis, Pulmonary | Tuberculosis, Multidrug-Resistant | Tuberculosis, MDRPeru, Vietnam, Moldova, Republic of, Mongolia, Pakistan, Philippines, South Africa
-
Genentech, Inc.Hoffmann-La RocheCompletedIdiopathic Pulmonary FibrosisUnited States
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary DiseaseUnited States
-
AstraZenecaQuintiles, Inc.Completed
-
Boehringer IngelheimCompleted12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPDPulmonary Disease, Chronic ObstructiveGermany, Italy, Switzerland, South Africa
-
Panagiota GrivaCompletedCompliance, Patient | AtelectasisGreece
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, United Kingdom
-
Boston Scientific CorporationCompletedSolitary Pulmonary Nodule | Biopsy, Fine-NeedleUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Russian Federation, Chile, South Africa, Romania, Slovakia
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseRomania, Lithuania, Canada, France, Hungary, India, South Africa, Korea, Republic of, Latvia, United Kingdom
-
Aeris TherapeuticsCompletedChronic Obstructive Pulmonary Disease | Pulmonary EmphysemaUnited States
-
Medical University of South CarolinaJohns Hopkins University; Mayo Clinic; Washington University School of Medicine; Medstar Health Research Institute and other collaboratorsCompletedPulmonary Lesions | Pulmonary Nodules | Pulmonary MassUnited States
-
GlaxoSmithKlineCompleted
-
Medical University of South CarolinaHoffmann-La RocheTerminated
-
Biosplice Therapeutics, Inc.WithdrawnIdiopathic Pulmonary FibrosisAustralia, New Zealand
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveTaiwan, Korea, Republic of, China, Australia
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, Austria, Canada, Germany, Greece, New Zealand, Norway, Slovakia, South Africa, Sweden